GILEAD SCIENCES, INC. for GILEAD SCIENCES INC

Veterans VET

Education related to Hepatitis C. FY18/19 Military Construction VA Appropriations bill.

Contacted: U.S. Trade Representative (USTR); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; State, Dept of (DOS)

Foreign Relations FOR

Issues related to pharmaceuticals and international finance for health services. Access to medicines and intellectual property protection.

Contacted: State, Dept of (DOS); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Indian/Native American Affairs IND

Education related to Hepatitis C in American Indian population.

Contacted: U.S. Trade Representative (USTR); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Trade (domestic/foreign) TRD

International trade and protection of intellectual property; compulsory licensing issues in multiple countries.

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS)

Copyright/Patent/Trademark CPT

Technology transfer, patent rights and funding, patent reform legislation. Issues related to pharmaceuticals and intellectual property protection.

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); SENATE

Health Issues HCR

Ryan White Care Act reauthorization; Hepatitis C policy; PEPFAR reauthorization; HIV/AIDS research, testing and treatment. HCV screening and linkage to care programs; coverage and reimbursement policy for HCV and HIV portfolio. Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program; implementation of section 340B drug discount program. Prison population and hepatitis C. International trade and protection of intellectual property. Support for H.R. 5353/S.2579 - Eliminating Opioid Related Infectious Diseases Act of 2018. FDA safety requirements.

Contacted: SENATE; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Bills named: S. 2579 (115th), H.R. 5353 (115th)

Medicare/Medicaid MMM

HCV testing, screening and linkage to care programs. Federal program coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products. Coverage of pharmaceuticals, cost-sharing and other access issues; issues related to coverage and reimbursement of pharmaceuticals. Medicaid duplicate discounts.

Contacted: SENATE; State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR)

Budget/Appropriations BUD

Funding for HCV and public health activities via appropriations. Pharmaceutical policy as it relates to payments under the 340B program.

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); SENATE; U.S. Trade Representative (USTR)

Taxation/Internal Revenue Code TAX

Implementation of the Tax Cuts and Jobs Act of 2017 (P.L. 115-97)

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); SENATE